ARTICLE | Company News
SmithKline vaccine license from MedImmune
July 19, 2000 7:00 AM UTC
SBH received from MEDI worldwide exclusive rights to develop and commercialize a Streptococcus pneumoniae vaccine technology in preclinical evaluation. MEDI may receive an up-front payment and milesto...